|
|
 |
|
Viewing report
|
|
|
|
Industry Insight - Indian Bulk Drugs
CYGNUS Business Consulting & Research, Oct 2010, Pages: 176
The Indian pharmaceuticals market is expected to grow from the current US$19 billion to US$32 billion by 2015 at CAGR of 18-19% whereas domestic sales is geared to expand nearly about US$ 20 billion by 2015 from an estimated size of US$11.72 billion in 2009. India has more than 100 US FDA-approved manufacturing facilities. India’s bulk drug industry is estimated to be worth US$16.91 billion by 2014. India ranks third in terms of volume among the top 15 drug manufacturing countries. Nearly 70% of the bulk drugs manufactured are exported to more than 50 countries. Contract manufacturing has been driving the bulk drugs exports in the last few years. Global pharmaceutical companies have been outsourcing contract manufacturing to Indian companies to cut costs. The Indian pharma outsourcing market, including contract chemistry and biology research, clinical trials and contract manufacturing is roughly valued at around US$1 billion in 2009 each, growing at a CAGR of 25%. Contract Manufacturing Outsourcing market stood at US$986m in 2009 and is expected to grow at a CAGR of 41.7% to reach US$5.63 billion by 2014.
In view of the significant growth potential of Indian bulk drugs industry, Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight, covering present market scenario, growth drivers, critical success factors, regulatory issues along with the major players and their key financials. This report consists of 10 chapters. The overview of global bulk drugs market provides bulk drugs and segmental market size, the major players, and mergers and acquisition which is followed by overview of Indian bulk drugs industry. The report then moves on to discuss industry regulations, growth drivers, and issues and challenges. The report comprises the profiles of 19 leading bulk drugs manufacturers with their SWOT analysis and outlook. The industry’s critical success factors and future outlook are discussed to provide key inputs for understanding the industry.
The report will be useful to senior executives associated with the industry, bankers, private equity players, investors, students, research scholars and industry analysts who need relevant industry inputs for their work.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
